Wilke H - Search Results

1

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C, et al. Harstrick A, et al. Among authors: wilke h. J Clin Oncol. 1991 Sep;9(9):1549-55. doi: 10.1200/JCO.1991.9.9.1549. J Clin Oncol. 1991. PMID: 1651992

2

A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.

Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H. Schöber C, et al. Among authors: wilke hj. Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40. Semin Oncol. 1992. PMID: 1557639 Clinical Trial.

3

Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.

Harstrick A, Bokemeyer C, Preusser P, Köhne-Wömpner CH, Meyer HJ, Stahl M, Knipp H, Schmoll HJ, Wilke H. Harstrick A, et al. Among authors: wilke h. Cancer Chemother Pharmacol. 1992;29(4):321-2. doi: 10.1007/BF00685952. Cancer Chemother Pharmacol. 1992. PMID: 1537080 Clinical Trial.

4

Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors.

Schmoll HJ, Bokemeyer C, Harstrick A, Illiger HJ, Metzner B, Ruther U, Osternamm A, Preiss J, Wilke H, Hohnloser J, et al. Schmoll HJ, et al. Among authors: wilke h. Pathol Biol (Paris). 1992 Nov;39(9):961. Pathol Biol (Paris). 1992. PMID: 1538953 No abstract available.

5

Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial.

Schmoll HJ, Köhne-Wömpner CH, Hiddemann W, Knipp H, Wilke H, Bodenstein H, Schöffski P, Bokemeyer C, Lohrmann HP, Preiss J, et al. Schmoll HJ, et al. Among authors: wilke h. Semin Oncol. 1992 Apr;19(2 Suppl 3):191-6. Semin Oncol. 1992. PMID: 1557646 Clinical Trial.

6

A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.

Stahl M, Wilke H, Schmoll HJ, Schöber C, Diedrich H, Casper J, Freund M, Poliwoda H. Stahl M, et al. Among authors: wilke h. Ann Oncol. 1992 Feb;3(2):167-8. doi: 10.1093/oxfordjournals.annonc.a058136. Ann Oncol. 1992. PMID: 1606089 Free article. Clinical Trial.

7

Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines.

Harstrick A, Casper J, Köhne-Wömpner H, Wilke H, Schmoll HJ, Poliwoda H. Harstrick A, et al. Among authors: wilke h. Invest New Drugs. 1990;8 Suppl 1:S19-24. doi: 10.1007/BF00171980. Invest New Drugs. 1990. PMID: 1696245

8

High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study.

Harstrick A, Schmoll HJ, Wilke H, Schöber C, Stahl M, Wömpner CK, Bokemeyer C, Dölken G, Burk K, Poliwoda H. Harstrick A, et al. Among authors: wilke h. Ann Oncol. 1990 Sep;1(5):375-6. doi: 10.1093/oxfordjournals.annonc.a057778. Ann Oncol. 1990. PMID: 2261377 Free article. Clinical Trial.

9

Etoposide and split-dose cisplatin in small-cell lung cancer.

Wilke H, Achterrath W, Schmoll HJ, Gunzer U, Preusser P, Lenaz L. Wilke H, et al. Am J Clin Oncol. 1988 Oct;11(5):572-8. doi: 10.1097/00000421-198810000-00013. Am J Clin Oncol. 1988. PMID: 2845770

10

Folinic acid (FA) plus 5-fluorouracil (FU) in progressive advanced colorectal cancer.

Wilke H, Schmoll HJ, Schöber C, Stahl M, Preusser P, Freund M, Poliwoda H. Wilke H, et al. Biomed Pharmacother. 1988;42(6):373-80. Biomed Pharmacother. 1988. PMID: 3064821 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters